GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veeva Systems Inc (NYSE:VEEV) » Definitions » Cash And Cash Equivalents

Veeva Systems (Veeva Systems) Cash And Cash Equivalents : $703 Mil (As of Jan. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Veeva Systems Cash And Cash Equivalents?

Veeva Systems's quarterly cash and cash equivalents increased from Jul. 2023 ($742.61 Mil) to Oct. 2023 ($743.71 Mil) but then stayed the same from Oct. 2023 ($743.71 Mil) to Jan. 2024 ($703.49 Mil).

Veeva Systems's annual cash and cash equivalents declined from Jan. 2022 ($1,138.04 Mil) to Jan. 2023 ($886.47 Mil) and declined from Jan. 2023 ($886.47 Mil) to Jan. 2024 ($703.49 Mil).


Veeva Systems Cash And Cash Equivalents Historical Data

The historical data trend for Veeva Systems's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veeva Systems Cash And Cash Equivalents Chart

Veeva Systems Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 476.73 730.50 1,138.04 886.47 703.49

Veeva Systems Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 886.47 1,093.63 742.61 743.71 703.49

Veeva Systems Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Veeva Systems  (NYSE:VEEV) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Veeva Systems Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Veeva Systems's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Veeva Systems (Veeva Systems) Business Description

Address
4280 Hacienda Drive, Pleasanton, CA, USA, 94588
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Executives
Thomas D. Schwenger officer: President and COO C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Alan Mateo officer: EVP Global Sales C/O VEEVA SYSTEMS, 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Eleni Nitsa Zuppas officer: Chief Marketing Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Matthew J Wallach officer: President C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Mary Lynne Hedley director C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Timothy S Cabral officer: Chief Financial Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Paul J Sekhri director C/O VEEVA SYSTEMS INC., 4637 CHABOT DRIVE, SUITE 210, PLEASANTON CA 94588
Kristine Diamond officer: Chief Accounting Officer 345 ENCINAL STREET, SANTA CRUZ CA 95060
Paul Edward Chamberlain director C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Michele O'connor officer: Chief Accounting Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Peter P Gassner director, 10 percent owner, officer: Chief Executive Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Codd Ronald E F director C/O INTERWOVEN INC, 803 11TH AVE, SUNNYVALE CA 94089
Nimrata Hunt director IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Priscilla Hung director C/O GUIDEWIRE SOFTWARE, INC., 970 PARK PL, SUITE 200, SAN MATEO CA 94403
Marshall Mohr director C/O INTUITIVE SURGICAL, INC, 1266 KIFER ROAD, SUNNYVALE CA 94086